1151520: Bard XenMatrix AB Surgical Graft: 15cm x 20cm

Sign in to add this product to your favorites!
Price: | $7,000.00 per box of 1 |
---|---|
Quantity: | |
In Stock: | 1 box of 1 |
Expiration: | 08-2025 |
Additional Details
C.R. Bard BD XenMatrix™ AB Surgical Graft
XenMatrix™ AB is the first antibacterial-coated, non-crosslinked porcine dermal graft proven to inhibit the colonization of MRSA, E. coli, and other bacteria in preclinical models. It uses a combination of well-characterized antibiotics, Rifampin and Minocycline, to offer an unmatched level of graft protection in challenging ventral hernia repair.
Manufacturer
C.R. Bard (a part of BD - Becton, Dickinson and Company) was a global leader in the development and manufacturing of innovative medical technologies. Known for their high-quality products, Bard specialized in solutions for vascular access, urology, oncology, and surgical specialties. Their product portfolio included catheters, biopsy devices, implantable ports, and hernia repair systems, designed to enhance patient care and procedural efficiency. As part of BD, the legacy of C.R. Bard continues to drive advancements in healthcare, delivering trusted solutions that improve outcomes for patients and providers worldwide.